Highlights from the CHMP July 2026 Meeting are out! Six oncology calls came out of the July CHMP meeting. Below are the key takeaways: 1) ADCs own the front line. 👉 Enhertu and Trodelvy both cleared first-line metastatic breast settings in combination. 2) Breast cancer is where the density is. 👉 All three positive opinions are in the Breast Cancer space 3) A met endpoint is not an EU approval. 👉 POTOMAC succeeded, and the FDA approved. CHMP still questioned the benefit-ris